Entourage Health Corp. (formerly WeedMD Inc.)
(
TSX-V:ENTG)
(OTCQX:WDDMF)
(FSE:4WE) (“
Entourage” or the
“
Company”), is pleased to announce that as part of
its corporate name change and rebrand from “WeedMD Inc.” to
“Entourage Health Corp.”, the Company’s common shares
(“
Common Shares”) will continue to be publicly
traded on the TSX Venture Exchange (the “
TSXV”)
under the new ticker symbol “
ENTG”, with a new
CUSIP number of 293861100 and ISIN number of CA2938611001. These
changes are effective today at market open.
In connection with the name change, the Company
also confirmed its convertible debentures maturing September 25,
2022 (the “Debentures”), Common Share purchase
warrants expiring September 25, 2022 (the “2022
Warrants”), and Common Share purchase warrants expiring
March 12, 2023 (the “2023 Warrants”), and their
respective ticker symbols “ENTG.DB”,
“ENTG.WT”, and “ENTG.WT.A”, will
also commence trading today on the TSXV.
The new CUSIP for the Debentures is 293861AA8
and the ISIN number is CA293861AA82. The new CUSIP for the 2022
Warrants is 293861126 and the ISIN number is CA2938611266. The new
CUSIP for the 2023 Warrants is 293861118 and the ISIN number is
CA2938611183. No action is required by existing securityholders of
the Company with respect to the name change. Outstanding Common
Shares, Debentures and Warrants certificates are not affected by
the name change and do not need to be exchanged.
Following confirmation of the name change, the
Company also announced its newly launched Entourage Health website
is now active and can be accessed here. The website and branding
captures the Company’s evolution into a producer of award-winning
cannabis brands and products - crafted with pride by people who
care.
To access our corporate video, visit us here and
to access our latest investor presentation and corporate deck
here.
About Entourage Health
Corp.
Entourage Health Corp. (formerly WeedMD Inc.) is
the publicly traded parent company of WeedMD RX Inc. a licence
holder producing and distributing cannabis products for both the
medical and adult-use markets. The Company owns and operates a
158-acre state-of-the-art greenhouse, outdoor and processing
facility located in Strathroy, ON as well as a fully-licensed
26,000 sq. ft. Aylmer, ON processing facility, specializing in
cannabis extraction. With the addition of Starseed Medicinal, a
medical-centric brand, Entourage has expanded its multi-channeled
distribution strategy. Starseed’s industry-first, exclusive
partnership with LiUNA, the largest construction union in Canada,
along with employers and union groups complements Entourage’s
direct sales to medical patients. In July 2021, Entourage signed a
definitive agreement to acquire craft cultivator CannTx Life
Sciences which operates out of its state-of-the-art micropropogaton
and specialty extraction facility in Guelph, Ontario. Upon the
acquisition’s expected closing in late August 2021, craft brand
Royal City Cannabis will be added to Entourage’s elite product
portfolio. The Company maintains strategic relationships in the
seniors’ market and supply agreements with Shoppers Drug Mart as
well as eight provincial distribution agencies where adult-use
brands Color Cannabis and Saturday Cannabis are sold. Entourage is
also the exclusive Canadian producer and distributor of
award-winning U.S.-based wellness brand Mary’s Medicinals sold in
both medical and adult-use channels.
For more information, please visit us at
www.entouragehealthcorp.com
Follow Entourage and its brands on
LinkedIn
Twitter: Entourage,
Color Cannabis, Saturday
Cannabis &
Starseed
Instagram: Entourage,
Color Cannabis, Saturday
Cannabis &
Starseed
For further information, please
contact:
For Investor Enquiries:Valter PintoManaging
DirectorKCSA Strategic
Communications1-212-896-1254weedmd@kcsa.com
For Media Enquiries:Marianella delaBarreraSVP,
Communications & Corporate
Affairs416-897-6644marianella@weedmd.com
Forward Looking Information
This press release contains "forward-looking information" within
the meaning of applicable Canadian securities legislation which are
based upon Entourage's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information can be identified by the use of
forward-looking terminology such as "expect", "likely", "may",
"will", "should", "intend", "anticipate", "potential", "proposed",
"estimate" and other similar words, including negative and
grammatical variations thereof, or statements that certain events
or conditions "may", "would" or "will" happen, or by discussions of
strategy
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions and views of future events which management believes to
be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry
in Canada generally; the ability of Entourage to
implement its business strategies; the COVID-19 pandemic;
competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities regulatory authorities on SEDAR at
www.sedar.com. The risk factors and other factors noted in the
disclosure documents could cause actual events or results to differ
materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jul 2023 to Jul 2024